drugset / Trial / NCT05755906
A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a 12-week study to evaluate the efficacy and safety of budesonide and formoterol fumarate metered dose inhaler relative to budesonide metered dose inhaler in adults and adolescents with inadequately controlled asthma.
Timeline
- Start
- 2023-02-27
- Primary completion
- 2024-11-19
- Completion
- 2024-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Formoterol | Other / unclassified | 9.6 ug | Inhaled |
| Comparator | Budesonide | Small molecule | 160 ug | Inhaled |